The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey: Epidemiology of drug use disorders in Iran
Abstract
BACKGROUND AND AIMS: Drug abuse is a significant social and public health problem in Iran. The present study aimed to provide prevalence estimates and information on correlates of illicit drug use disorder and opioid dependence, as well as service use for these disorders in Iran. DESIGN, SETTING AND PARTICIPANTS: This report is based on the Iranian household Mental Health Survey (IranMHS) conducted in 2011. A three-stage probability sampling was employed. Face-to-face interviews by trained psychologists were carried out with a nationally representative sample of 7841 individuals (3366 men and 4475 women) aged 15-64 years. MEASUREMENTS: The Composite International Diagnostic Interview and questionnaires for socio-demographic correlates and service use. FINDINGS: The prevalence of 12-month use disorders for any illicit drug according to DSM-IV and DSM-5 criteria were 2.09% [95% confidence interval (CI) = 1.70-2.47%] and 2.44% (95% CI = 2.03-2.85%), respectively. Opioid use disorders, and opium in particular, were the most common use disorder. The odds of drug use disorders were greater in men than in women, in previously married participants than in currently or never married participants, and in participants with lower socio-economic status than in those with higher socio-economic status (all P-values <0.05). Approximately half of those with drug use disorders and 40% with opioid dependence had a 12-month unmet need for treatment. Self-help groups were the most common type of service used, followed by obtaining medication from pharmacies directly and outpatient treatment services. CONCLUSIONS: Opioid use disorders are the most common type of drug use disorders in Iran, setting Iran apart from many other countries. Patterns of service use suggest a large unmet need for drug use disorder treatment in Iran.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013
Steel, Z., Marnane, C., Iranpour, C., Chey, T., Jackson, J. W., Patel, V., & Silove, D. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu038 · Cited by 2,846
Extent of illicit drug use and dependence, and their contribution to the global burden of disease
Degenhardt, L., & Hall, W. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61138-0 · Cited by 1,303
Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.566 · Cited by 1,152
Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.031 · Cited by 941
Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., Freedman, G., Burstein, R., Johns, N., Engell, R. E., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61530-5 · Cited by 852
JANE-LLOPIS, E., & MATYTSINA, I. (2006) · Drug and Alcohol Review · doi:10.1080/09595230600944461 · Cited by 497
Epidemiology of substance use disorders
Merikangas, K. R., & McClair, V. L. (2012) · Human Genetics · doi:10.1007/s00439-012-1168-0 · Cited by 419
Farrell, M., Howes, S., Bebbington, P., Brugha, T., Jenkins, R., Lewis, G., Marsden, J., Taylor, C., & Meltzer, H. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.5.432 · Cited by 294
Prevalence and treatment of mental disorders in Lebanon: a national epidemiological survey
Karam, E. G., Mneimneh, Z. N., Karam, A. N., Fayyad, J. A., Nasser, S. C., Chatterji, S., & Kessler, R. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68427-4 · Cited by 290
Sharifi, V., Amin‐Esmaeili, M., Hajebi, A., Motevalian, S. A., Radgoodarzi, R., Hefazi, M., & Rahimi‐Movaghar, A. (2015) · PubMed · Cited by 230
Self-citationForouzanfar, M. H., Sepanlou, S. G., Shahraz, S., Dicker, D., Naghavi, P., Pourmalek, F., Mokdad, A. H., Lozano, R., Vos, T., Asadi-Lari, M., et al. (2014) · PubMed · Cited by 185
Oakley Browne, M. A., Elisabeth Wells, J., Scott, K. M., Mcgee, M. A., & For The New Zealand Mental Health Survey Research Team (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01905.x · Cited by 172
Prevalence of Co-Occurring Substance Use and other Mental Disorders in the Canadian Population
Rush, B., Urbanoski, K., Bassani, D., Castel, S., Wild, T. C., Strike, C., Kimberley, D., & Somers, J. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805301206 · Cited by 168
Degenhardt, L. J., Bucello, C., Calabria, B., Nelson, P. K., Roberts, A., Hall, W., Lynskey, M. T., Wiessing, L. G., Mora, M. E. M., Clark, N., et al. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.032 · Cited by 136
DSM-IV to DSM-5: the impact of proposed revisions on diagnosis of alcohol use disorders
Agrawal, A., Heath, A. C., & Lynskey, M. T. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03517.x · Cited by 125
An evaluation of the proposed DSM‐5 alcohol use disorder criteria using Australian national data
Mewton, L. R., Slade, T. N., McBride, O., Grove, R., & Teesson, M. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03340.x · Cited by 104
Teesson, M., Baillie, A., Lynskey, M. T., Manor, B. R., & Degenhardt, L. J. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.06.007 · Cited by 101
Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010.
Naghavi, M., Shahraz, S., Sepanlou, S. G., Dicker, D., Naghavi, P., Pourmalek, F., Mokdad, A. H., Lozano, R., Vos, T., Asadi-Lari, M., et al. (2014) · PubMed · Cited by 93
Iranian mental health survey: design and field proced.
Rahimi‐Movaghar, A., Amin‐Esmaeili, M., Sharifi, V., Hajebi, A., Radgoodarzi, R., Hefazi, M., & Motevalian, S. A. (2014) · Europe PMC (PubMed Central) · Cited by 62
Self-citationHosseinpoor, A. R., Naghavi, M., Alavian, S. M., Speybroeck, N., Jamshidi, H., & Vega, J. (2007) · PubMed · Cited by 47
Harrington, M., Robinson, J. A., Bolton, J. M., Sareen, J., & Bolton, J. M. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601107 · Cited by 44
Characteristics of Iranian Women Seeking Drug Treatment
Dolan, K. A., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., & Mokri, A. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2694 · Cited by 40
Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan
Tominaga, M., Kawakami, N., Ono, Y., Nakane, Y., Nakamura, Y., Tachimori, H., Iwata, N., Uda, H., Nakane, H., Watanabe, M., et al. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0499-1 · Cited by 37
The utilization of health services
Béland, F. (1982) · Social Science & Medicine · doi:10.1016/0277-9536(82)90162-9 · Cited by 35
Amin‐Esmaeili, M., Rahimi‐Movaghar, A., Razaghi, E. M., Baghestani, A. R., & Jafari, S. (2012) · Hepatitis Monthly · doi:10.5812/kowsar.1735143x.806 · Cited by 34
Self-citationPharmacological therapies for maintenance treatments of opium dependence
Rahimi‐Movaghar, A., Amin‐Esmaeili, M., Hefazi, M., & Nooraie, R. Y. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007775.pub2 · Cited by 28
Self-citationThe translation and psychometric assessment of the persian version of the sheehan disability scale.
Amin‐Esmaeili, M., Motevalian, S. A., Rahimi‐Movaghar, A., Hajebi, A., Hefazi, M., Radgoodarzi, R., & Sharifi, V. (2014) · PubMed Central · Cited by 25
Self-citationReliability of a patient survey assessing "Short Form Injury Questionnaire 7" in Iran.
Sharif-Alhoseini, M., Saadat, S., Rahimi‐Movaghar, A., Motevalian, A., Amin‐Esmaeili, M., Hefazi, M., & Rahimi‐Movaghar, V. (2012) · PubMed · Cited by 11
Self-citation
Cited by
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Self-citationStrang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Metadata
- Authors
- Amin-Esmaeili, M., Rahimi-Movaghar, A., Sharifi, V., Hajebi, A., Radgoodarzi, R., Mojtabai, R., Hefazi, M., & Motevalian, A.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2016-07-27
- Volume
- 111
- Issue
- 10
- Pages
- 1836-1847
- ISSN
- 0965-2140 (ISSN-L)
- OpenAlex
- W2394109200
- Cited by
- 265
- References
- 31
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.